These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
791 related articles for article (PubMed ID: 32934754)
1. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma. Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis. Zhou J; Hui X; Mao Y; Fan L Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829 [TBL] [Abstract][Full Text] [Related]
3. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis. Shang M; Zhang L; Chen X; Zheng S Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587 [TBL] [Abstract][Full Text] [Related]
4. The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma. Luan H; He Y; Zhang T; Su Y; Zhou L BMC Cancer; 2022 Apr; 22(1):463. PubMed ID: 35477379 [TBL] [Abstract][Full Text] [Related]
5. Identifying Ding J; Liu Y; Lai Y PeerJ; 2020; 8():e10419. PubMed ID: 33282565 [TBL] [Abstract][Full Text] [Related]
6. Identification of key regulators of pancreatic ductal adenocarcinoma using bioinformatics analysis of microarray data. Li N; Zhao X; You S Medicine (Baltimore); 2019 Jan; 98(2):e14074. PubMed ID: 30633213 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatic Analysis Suggests That Three Hub Genes May Be a Vital Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma. Chang X; Yang MF; Fan W; Wang LS; Yao J; Li ZS; Li DF J Comput Biol; 2020 Nov; 27(11):1595-1609. PubMed ID: 32216644 [TBL] [Abstract][Full Text] [Related]
8. Gene signature and connectivity mapping to assist with drug prediction for pancreatic ductal adenocarcinoma. Xiao Y; Zhang B; Cloyd JM; Xu G; Du S; Mao Y; Pawlik TM Surg Oncol; 2022 Sep; 44():101849. PubMed ID: 36116415 [TBL] [Abstract][Full Text] [Related]
9. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma. Fan L; Wang X; Chang Q; Wang Y; Yang W; Liu L Medicine (Baltimore); 2022 Oct; 101(42):e30966. PubMed ID: 36281157 [TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma. Zheng X; Liu X; Zheng H; Wang H; Hong D Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696 [TBL] [Abstract][Full Text] [Related]
11. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma. Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384 [TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets. Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501 [TBL] [Abstract][Full Text] [Related]
13. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis. You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731 [TBL] [Abstract][Full Text] [Related]
14. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Zhang J; Sun H; Liu S; Huang W; Gu J; Zhao Z; Qin H; Luo L; Yang J; Fang Y; Ge J; Ni B; Wang H Aging (Albany NY); 2020 Nov; 12(22):23217-23232. PubMed ID: 33221741 [TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods. Lu Y; Li C; Chen H; Zhong W Mol Biol Rep; 2018 Dec; 45(6):1799-1807. PubMed ID: 30173393 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer. Lu Q; Zhang Y; Chen X; Gu W; Ji X; Chen Z Medicine (Baltimore); 2021 Mar; 100(12):e24957. PubMed ID: 33761652 [TBL] [Abstract][Full Text] [Related]
17. Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes. de Koning W; Latifi D; Li Y; van Eijck CHJ; Stubbs AP; Mustafa DAM Front Immunol; 2021; 12():649061. PubMed ID: 33986743 [TBL] [Abstract][Full Text] [Related]
18. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Zhuang H; Wang S; Chen B; Zhang Z; Ma Z; Li Z; Liu C; Zhou Z; Gong Y; Huang S; Hou B; Chen Y; Zhang C Front Immunol; 2021; 12():790661. PubMed ID: 34925373 [TBL] [Abstract][Full Text] [Related]
20. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma. Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S Front Immunol; 2021; 12():648917. PubMed ID: 33777046 [No Abstract] [Full Text] [Related] [Next] [New Search]